Non-pegylated liposomal doxorubicin in metastatic breast cancer patients: a valuable therapeutic option requiring caution

MeSH terms

• Adult
• Aged
• Antibiotics, Antineoplastic / administration & dosage*
• Antibiotics, Antineoplastic / adverse effects
• Antibiotics, Antineoplastic / therapeutic use
• Breast Neoplasms / drug therapy*
• Doxorubicin / administration & dosage*
• Doxorubicin / adverse effects
• Doxorubicin / therapeutic use
• Drug Carriers
• Female
• Heart Failure / chemically induced
• Hematologic Diseases / chemically induced
• Humans
• Liposomes
• Middle Aged
• Neoplasm Metastasis
• Prospective Studies
• Treatment Outcome